Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.
Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.
复制标题
单克隆抗体 R24 和白细胞介素 2 组合治疗转移性黑色素瘤患者的 I 期评估。
作者：
Bajorin,DF;Chapman,PB;Wong,G;Coit,DG;Kunicka,J;Dimaggio,J;Cordon-Cardo,C;Urmacher,C;Dantes,L;Templeton,MA
